doc. MUDr. Daniela Žáčková, Ph.D.

Department vice-head, Department of Internal Medicine, Hematology and Oncology

correspondence Address:
Jihlavská 340/20, 625 00 Brno

phone:	+420 532 23 2838, 3603
e‑mail:	Zackova.Daniela@fnbrno.cz

social and academic networks:

Basic information

Supervision

Qualifications

Publications

Type

Total number of publications: 232

2010

A guide to cytogenetic and FISH monitiring

ŽÁČKOVÁ D

Appeared in Conference without Proceedings

Year: 2010, type: Appeared in Conference without Proceedings
Adverse events of TKIs-their management and their role in choosing second line therapy.

ŽÁČKOVÁ Daniela

Appeared in Conference without Proceedings

Year: 2010, type: Appeared in Conference without Proceedings
Analýza mutací BCR-ABL u CML pacientů rezistentních k imatinibu umožňuje poskytnout „terapii šitou na míru“

ŠŤASTNÝ M. MACHOVÁ POLÁKOVÁ K. KLAMOVÁ H. ŽÁČKOVÁ Daniela VOGLOVÁ J. KARAS M. MORAVCOVÁ J. FABER E.

Article in Periodical

Transfuze a hematologie dnes, year: 2010, volume: 16, edition: 1
Constant BCR-ABL transcript level >or=0.1% (IS) in patients with CML responding to imatinib with complete cytogenetic remission may indicate mutation analysis.

MACHOVÁ POLÁKOVÁ Kateřina POLÍVKOVÁ Václava RULCOVÁ Jana KLAMOVÁ Hana JURČEK Tomáš DVOŘÁKOVÁ Dana ŽÁČKOVÁ Daniela POSPÍŠIL Zdeněk MAYER Jiří MORAVCOVÁ Jana

Article in Periodical

Experimental hematology, year: 2010, volume: 38, edition: 1
Dasatinib in imatinib-resistant or -intolerant CML patients: data from the clinical practice of 6 hematological centers in the Czech Republic

KLAMOVA H. FABER E. ŽÁČKOVÁ Daniela MARKOVA M. VOGLOVA J. CMUNT E. NOVAKOVA L. MACHOVA-POLAKOVA K. MORAVCOVA J. DVOŘÁKOVÁ Dana MICHALOVA K. BREZINOVA J. OLTOVÁ Alexandra JAROŠOVÁ Marie CETKOVSKÝ Petr INDRAK K. MAYER Jiří

Article in Periodical

Neoplasma, year: 2010, volume: 57, edition: 4, DOI
Detection of an aberrant form of E13A2 BCR-ABL transcript causing failure of molecular diagnostics in patient with chronic myeloid leukemia (CML)

JURČEK Tomáš RÁZGA Filip JEŽÍŠKOVÁ Ivana ŽÁČKOVÁ D. MAYER Jiří DVOŘÁKOVÁ Dana

Conference abstract

Year: 2010, type: Conference abstract
EUROPEAN SUB-REGISTRY OF CHRONIC MYELOID LEUKEMIA (CML) PATIENTS (PTS) IN FAILURE AFTER IMATINIB THERAPY (IFP): RATIONALE, STUDY DESIGN AND CURRENT STATUS. A STUDY FROM THE EUROPEAN LEUKEMIANET (ELN)

GUILHOT J TARTARIN F HOCHHAUS A SAUSSELE S NICOLINI F ROSTI G STEEGMAN JL SACHA T COUTRE P Le NAGLER A ABRUZZESE E HEIM D CLARK R STENTOFT J FABER E PORKKA K CERVANTES F HÖGLUND M O BRIEN S THALER J TURKINA A OSSENKOPPELE G ŽÁČKOVÁ Daniela KLAMOVÁ H GAMBACORTI C PFIRRMANN M HASFORD J HELMANN R

Conference abstract

Year: 2010, type: Conference abstract
Failure of molecular diagnostics in chronic myeloid leukemia - an aberrant form of e13a2 BCR-ABL transcript causing false-negative results by standard PCR.

JURČEK Tomáš RÁZGA Filip JEŽÍŠKOVÁ Ivana DVOŘÁKOVÁ Dana ŽÁČKOVÁ Daniela TOMÁŠIKOVÁ Lenka OLTOVÁ Alexandra MAYER Jiří

Article in Periodical

LEUKEMIA & LYMPHOMA, year: 2010, volume: 51, edition: 3
Frekvence mutací v BCR-ABL kinázové doméně u pacientů s chronickou myeloidní leukémií (CML) léčených tyrozinkinázovými inhibitory - zkušenosti IHOK FN Brno

JURČEK Tomáš RÁZGA Filip ŽÁČKOVÁ Daniela DOBEŠOVÁ Blanka RÁČIL Zdeněk JEŽÍŠKOVÁ Ivana DVOŘÁKOVÁ Dana MAYER Jiří

Conference abstract

Year: 2010, type: Conference abstract
Chronická myeloidní leukemie v éře tyrozinkinázových inhibitorů

ŽÁČKOVÁ Daniela

Appeared in Conference without Proceedings

Year: 2010, type: Appeared in Conference without Proceedings

Projects

Teaching